BDX (Becton Dickinson) Tariff Resilience Score: 8/10 (As of Jun. 25, 2026)


BDX Becton Dickinson & Co BDX
76 GF Score
Price $151.38
GF Value $191.05
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Becton Dickinson Tariff Resilience Score?

Becton Dickinson BDX +2.44% 76 Tariff Resilience Score is 8 as of Jun. 25, 2026. GuruFocus rates BDX with a GF Score™ of 76/100 and a GF Value™ of $191.05 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 838 Medical Devices & Instruments companies, Becton Dickinson ranks better than 99.64% on this metric.

Becton Dickinson has the Tariff Resilience Score of 8, which implies that the company might have Highly Resilient.

Becton Dickinson has Becton Dickinson has a global manufacturing footprint, reducing single-region dependency. Its medical products often benefit from tariff exemptions. The company has a strong import/export balance and can adjust supply chains to mitigate tariff impacts.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Becton Dickinson might have Highly Resilient.

Becton Dickinson  (NYSE:BDX) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Becton Dickinson Tariff Resilience Score Related Terms

BDX vs MDLN, RMD, WST: Tariff Resilience Score Comparison

For the Medical Instruments & Supplies subindustry, Becton Dickinson's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Becton Dickinson Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Becton Dickinson's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Becton Dickinson's Tariff Resilience Score falls into.


BDX
76GF Score
Becton Dickinson & Co BDX
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 8 mean?
Becton Dickinson (BDX) has a Tariff Resilience Score of 8 as of Jun. 25, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Becton Dickinson ranks #3 out of 838 companies in the Medical Devices & Instruments industry, placing it in the top 0.40000000000001%.
Is Becton Dickinson's Tariff Resilience Score too high?
Becton Dickinson's current Tariff Resilience Score is 8. Based on the distribution chart, Becton Dickinson ranks #3 out of 838 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Becton Dickinson has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Becton Dickinson's Tariff Resilience Score compare to MDLN and RMD?
According to the Medical Devices & Instruments industry distribution chart, Becton Dickinson ranks #3 out of 838 companies for Tariff Resilience Score. This places Becton Dickinson in the top 0% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Becton Dickinson's current Tariff Resilience Score is 8. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Becton Dickinson stock overvalued right now?
Based on GuruFocus' analysis, Becton Dickinson (BDX) is currently considered Modestly Undervalued. The stock's GF Value™ is $191.05, compared to a current price of $151.38 — trading 20.8% below its estimated fair value. The current Tariff Resilience Score is 8. Becton Dickinson's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Becton Dickinson (BDX), the current Tariff Resilience Score is 8 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Becton Dickinson (BDX) Overvalued in 2026?

Based on GuruFocus' analysis, Becton Dickinson stock appears to be undervalued. The current stock price of $151.38 is trading 20.8% below its estimated GF Value™ of $191.05. GuruFocus considers Becton Dickinson to be Modestly Undervalued.

Key valuation signals for BDX:

  • Tariff Resilience Score: 8
  • GF Value™: $191.05 vs. price of $151.38 (20.8% below fair value)
  • GF Score™: 76/100 with 3 warning signs

No single metric tells the full story. See the BDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Becton Dickinson Business Description

Address 1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
76GF Score

Get the complete analysis for BDX

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$151.38
Price
$191.05
GF Value